UDFF Performance Evaluation ((Ultrason Derived Fat Fraction)

University Hospital, Angers

Status: Enrolling

Conditions: Non Alcoholic Fatty Liver Disease

Treatments: Diagnostic Test: UDFF

Study type: Observational

Funder types: Other

Identifiers

NCT06080386

202300122

Details and patient eligibility

About

The purpose of this study is to assess UDFF performance (compared to MRI)

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients who had hepatic ultrasound with available UDFF measurements and hepatic MRI (with steatosis quantification sequences) between 01/01/2022 and 31/09/2023 may be included.

Exclusion criteria

• chronic liver disease with a different etiology other than NAFL/NASH or mixed (hepatitis B or C, hemochromatosis, autoimmune hepatitis, Wilson's disease, cholestasic disease, alpha 1 antitrypsin deficiency),
• decompensated cirrhosis (ascites, jaundice, encephalopathy, rupture of esophageal varices),
• hepatocellular carcinoma.
• opposition to the use of its data

Trial design

100 participants in 1 patient group

one group

Description:

Patients who had during their care UDFF ultrasound measurements and liver MRI over the study period may be included in this study

Treatment:

Diagnostic Test: UDFF